2-190509197-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142645.2(NEMP2):āc.1246A>Gā(p.Thr416Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000193 in 1,551,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001142645.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEMP2 | NM_001142645.2 | c.1246A>G | p.Thr416Ala | missense_variant | 9/9 | ENST00000409150.8 | NP_001136117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEMP2 | ENST00000409150.8 | c.1246A>G | p.Thr416Ala | missense_variant | 9/9 | 2 | NM_001142645.2 | ENSP00000386292.3 | ||
MFSD6 | ENST00000412482.1 | n.*219T>C | non_coding_transcript_exon_variant | 4/4 | 3 | ENSP00000404511.1 | ||||
MFSD6 | ENST00000412482.1 | n.*219T>C | 3_prime_UTR_variant | 4/4 | 3 | ENSP00000404511.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000639 AC: 1AN: 156472Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82930
GnomAD4 exome AF: 0.00000143 AC: 2AN: 1399400Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 690198
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.1246A>G (p.T416A) alteration is located in exon 9 (coding exon 9) of the NEMP2 gene. This alteration results from a A to G substitution at nucleotide position 1246, causing the threonine (T) at amino acid position 416 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at